TIRUMOTECAN

Clinical trials for TIRUMOTECAN explained in plain language.

Never miss a new study

Get alerted when new TIRUMOTECAN trials appear

Sign up with your email to follow new studies for TIRUMOTECAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare kidney cancer: experimental drug targets aggressive tumors

Disease control Not yet recruiting

This study tests whether the drug sacituzumab tirumotecan can control advanced or spreading SMARCB1-deficient renal medullary carcinoma, a rare and aggressive kidney cancer. It is for 20 people whose cancer has worsened after at least one prior treatment. The main goal is to chec…

Matched conditions: TIRUMOTECAN

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 15, 2026 19:01 UTC

TIRUMOTECAN

Get alerted when new TIRUMOTECAN trials appear

New hope for rare kidney cancer: experimental drug targets aggressive tumors